SCHEMBL25661237

SCHEMBL25661237

c1ccc(-c2ccc(-c3ccc(-c4ccc(-c5nc(-n6c7ccccc7c7ccccc76)nc(-n6c7ccccc7c7ccccc76)n5)cc4)cc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MEN1 O00255 5/20 0.42
▸ KMT2A Q03164 5/20 0.42
▸ USP2 O75604 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ POLB P06746 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ADORA2B P29275 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ ACP1 P24666 2/20 0.39
▸ PDE5A O76074 1/20 0.38
▸ NTSR1 P30989 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25661279 1.00 ATM (0.45) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL11892567 1.00 ATM (0.45) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL23604843 1.00 ATM (0.45) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL14979081 0.96 L3MBTL1 (0.45) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL23268164 0.96 L3MBTL1 (0.45) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL19276002 0.96 L3MBTL1 (0.45) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL23332216 0.96 L3MBTL1 (0.45) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL18212407 0.96 L3MBTL1 (0.45) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL11892559 0.96 L3MBTL1 (0.48) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL14426204 0.95 ATM (0.41) ATML3MBTL1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150982-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2023-05-18 — — US disclosed
US-20230150982-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150982-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER CYP1B1, NOTUM, ORMDL3 ATM 4096/4885L3MBTL1 1652/4885KDM4E 2964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback